Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trialChan Joon Kim, Jong‐Seon Park, Hee-Yeol Kim et al.|The Lancet|2021Cited by 202
Three-Year Clinical Outcomes of a Thin-Strut Biodegradable-Polymer Everolimus-Eluting Stent in Patients With Acute Coronary SyndromeDoo Sun Sim, Jang‐Ho Bae, Dae Young Hyun et al.|Journal of Cardiovascular Intervention|2022Cited by 3
A Comparative Analysis of Two Biolimus-Eluting Biodegradable Stents: Evaluation of the Equivalence of 6 Months Versus 12 Months of DAPT Following Biolimus-Eluting Stent Implantation in Acute Coronary Syndrome (EQUUS)Jung‐Joon Cha, Albert Jang, Subin Lim et al.|Journal of Cardiovascular Intervention|2022Cited by 1
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Myeong‐Ho Yoon, Kyoung‐Woo Seo et al.|The Journal of invasive cardiology/The journal of invasive cardiology|2022Cited by 1